Viatris
Health Care
31
out of 100. Number 388 of 512, counting from the worst.
Where Viatris does well
- Arbitration 3 of 20. Few problems found.
- Renewals 0 of 20. Nothing found.
- No forced arbitration or class-action waiver anywhere in the Terms of Use — disputes go to real courts (Delaware), which is better than most peers. Viatris runs no consumer subscriptions, paid accounts, or direct product sales on its site, so there are zero auto-renew traps, cancellation mazes, or pricing tricks. The Privacy Notice explicitly promises not to rent, sell, or share personal data for third-party direct marketing without permission, names a Data Protection Officer anyone in any jurisdiction can contact, offers a separate California supplemental disclosure, lists a deletion right, and sets the children's-data cutoff at
- Much of the health-data collection is tied to legitimate regulated duties like pharmacovigilance (adverse-event reporting).
Even if the site's information harms you, Viatris caps everything it could ever owe you at $100 total — that's the maximum no matter what went wrong.
The fine print
6 clauses and findings from the draft archive, dated 1 October 2026. The plain English comes first; the small print is the company's own words. None of these has been checked yet.
-
Even if the site's information harms you, Viatris caps everything it could ever owe you at $100 total — that's the maximum no matter what went wrong.
TO THE FULLEST EXTENT POSSIBLY BY LAW, VIATRIS AND ANY OF ITS OFFICERS, DIRECTORS, EMPLOYEES OR AFFILIATES' MAXIMUM LIABILITY ARISING OUT OF OR IN CONNECTION WITH THE VIATRIS WEB SITES OR YOUR USE OF VIATRIS' CONTENT, REGARDLESS OF CAUSE OF ACTION (WHETHER IN CONTRACT, TORT, BREACH OF WARRANTY, OR OTHERWISE), WILL NOT EXCEED $100 IN THE AGGREGATE.
-
Visiting their site can mean Viatris collecting your medical conditions, drug use, biometric identifiers like facial geometry, and even guesses about your health conditions based on what you browse.
Health Data, such as conditions with which you have been diagnosed, symptoms that you have experienced after taking a Viatris product, drug usage, dietary restrictions, and other data relating to your physical, mental, or emotional health ... Biometric Data, such as facial geometry, iris patterns, and other biological measurements ... Health Data, such as inferences about the conditions that you might be experiencing based on your browsing activity.
-
Third parties can track what you do on Viatris sites and across other websites over time, and Viatris flat-out ignores your browser's Do Not Track signal.
We use cookies and related digital tracking technologies ('Cookies') in our emails and on our digital properties. This may involve us or third parties collecting Personal Data about online activities over time and across third party websites or online services ... We do not currently respond to web browser Do Not Track signals or similar mechanisms.
-
The no-selling promise only holds 'where required by applicable law' — elsewhere your data can be disclosed without consent, including to whoever buys Viatris in a merger or bankruptcy.
Where required by applicable law, Viatris does not rent, sell, or share Personal Data about you with non-affiliated persons for their direct marketing purposes unless we have your permission. Otherwise, however, we may disclose your Personal Data to the following categories of third parties without your consent as permitted by applicable law ... Parties involved in potential business transactions, including potential acquirers ... in the event of a merger ... spin-off, divestiture, or bankruptcy.
-
Viatris can change the rules whenever it wants and the new rules bind you — possibly just 30 days after they quietly publish them, with no direct notice to you.
Viatris may modify these terms and conditions and any associated policies on a going forward basis at any time by updating these legal notices, and we encourage you to review the terms and conditions because any such modifications will be binding on you ... the changes will become effective upon the earlier of your use of the site with actual notice of the change, or thirty days following publication.
-
You have just one year to bring any claim against Viatris or you lose it forever — and you must pay Viatris's legal bills if anything arises from your use of, or even reliance on, content they published themselves.
You and Viatris agree that any cause of action arising out of or related to the Web site must commence within one (1) year after the cause of action accrues. Otherwise, such cause of action is permanently barred ... You agree to defend, indemnify, and hold harmless Viatris ... alleging or resulting from or connected with (i) your use of or reliance on any third-party content, (ii) your use of or reliance on any Viatris content ...
How these were found
Terms of Use read live on 2026-10-01, page states 'Last revised on August 31, 2023.' Global Viatris Privacy Notice read live on 2026-10-01 states 'Last Updated: August 2026'; the US-locale copy (https://www.viatris.com/en-us/lm/united-states/viatris-privacy-notice) still shows 'Last Updated: September 2020' but contains identical clause text. The California supplemental disclosure is linked ('Click here') but its target content was not separately reviewed. All documents fetched directly from the official viatris.com domain; no mirrors needed. Viatris is a B2B/generics pharma company — its sites are informational, so several categories (auto-renew, consumer pricing) simply do not apply rather than being scored well; the health-data collection is partly explained by pharmaceutical safety-reporting obligations.
These notes come from the original draft and are not independent verification.